Concurrent hypofractionated chemoradiation (CRT) for head and neck squamous cancer with weekly cisplatin: A Lancashire experience.

Abstract

e17052 Background: Concurrent chemoradiation with intravenous cisplatin is the standard treatment for locally advanced head and neck cancer. We evaluated the use of hypofractionated radiotherapy and weekly concomitant cisplatin in our center. METHODS We retrospectively analysed 37 patients treated at our centre from August 2005 to November 2007. They… (More)

Topics

Cite this paper

@article{Sivaramalingam2009ConcurrentHC, title={Concurrent hypofractionated chemoradiation (CRT) for head and neck squamous cancer with weekly cisplatin: A Lancashire experience.}, author={Muthiah Sivaramalingam and A. Mehta and H. Wong and Naim Sidek}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2009}, volume={27 15_suppl}, pages={e17052} }